Evidence map›Paper›PMID 29071520›Full record

ReviewCurrent hypertension reports2017

An Update on Masked Hypertension.

D Edmund Anstey, Daniel Pugliese, Marwah Abdalla, Natalie A Bello, Raymond Givens, Daichi Shimbo

Abstract readReview
In one paragraph

Review in Current hypertension reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Clinical implementation of polygenic risk scores based on GWAS in the management of hypertension among Asian populations.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Latest Knowledge on the Role of Vitamin D in Hypertension.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Observational
  16. Epidemiological Impact and Clinical Consequences of Masked Hypertension: A Narrative Review.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2020
    Review
  17. Article
  18. Article
  19. Review
  20. Masked Hypertension: Whom and How to Screen?Current hypertension reports · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

D Edmund AnsteyColumbia University Medical Center, 622 West 168th Street, PH 9-310, New York, NY, 10032, USA. dea2123@cumc.columbia.edu.
Daniel PuglieseColumbia University Medical Center, 622 West 168th Street, PH 9-310, New York, NY, 10032, USA.
Marwah AbdallaColumbia University Medical Center, 622 West 168th Street, PH 9-310, New York, NY, 10032, USA.
Natalie A BelloColumbia University Medical Center, 622 West 168th Street, PH 9-310, New York, NY, 10032, USA.
Raymond GivensColumbia University Medical Center, 622 West 168th Street, PH 9-310, New York, NY, 10032, USA.
Daichi ShimboColumbia University Medical Center, 622 West 168th Street, PH 9-310, New York, NY, 10032, USA.

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
WORKSITE BLOOD PRESSURE STUDYP01HL047540 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI SLOAN, RICHARD P · 1993 to 2014
$27.7M
POSTDOCTORAL TRAINING IN CARDIOVASCULAR DISEASET32HL007854 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Marwah Abdalla, Michael Argenziano · 1996 to 2026
$14.7M
Institutional Career Development CoreKL2TR001874 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GENKINGER, JEANINE M., SHIMBO, DAICHI · 2016 to 2025
$13.6M
Incorporation of a Hypertension Working Group into the Jackson Heart StudyR01HL117323 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEWIS, CORA E, OGEDEGBE, OLUGBENGA G. · 2013 to 2024
$7.2M
Midcareer Investigator Award in Patient-Oriented Research in Human HypertensionK24HL125704 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHIMBO, DAICHI · 2015 to 2019
$573k
NCATS NIH HHS KL2 TR001874NCATS NIH HHS UL1 TR001873NHLBI NIH HHS K24 HL125704NHLBI NIH HHS P01 HL047540NHLBI NIH HHS R01 HL117323NHLBI NIH HHS T32 HL007854
6 · The paper itself

Abstract

Masked hypertension refers to the phenomenon of having a non-elevated clinic blood pressure (BP) despite having an elevated out-of-clinic BP. Masked hypertension is a common phenotype with a cardiovascular risk profile similar to that of sustained hypertension, defined as elevated clinic and out-of-clinic BP. Current guidelines offer little guidance on the best practices for detecting and treating masked hypertension. This is in part due to insufficient evidence upon which to base recommendations as many questions remain regarding the optimal clinical management of masked hypertension. In this review, we will discuss the recent literature on masked hypertension related to disease prevalence, diagnosis, screening strategies, adverse outcomes, and treatment, and will highlight critical areas for future research.

Indexed as

Antihypertensive AgentsBlood PressureBlood Pressure Monitoring, AmbulatoryHumansMasked HypertensionMass ScreeningPrevalenceRisk FactorsAntihypertensive AgentsAmbulatory blood pressure monitoringCardiovascular diseaseHome blood pressure monitoringHypertensionHypertension prevalenceMasked hypertension

Identifiers

PMID29071520
PMCPMC5723434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.